| Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. | |
| | |
MedLine Citation:
|
PMID: 12900304 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: This study characterized infant drug doses and breast-milk-to-plasma area-under-the-curve ratios for olanzapine and determined plasma concentrations and effects of this drug on breast-feeding infants. METHOD: Seven mother-infant nursing pairs were studied. Olanzapine was measured in plasma and milk with high-performance liquid chromatography over a dose interval (for six patients) or at a single time after dose ingestion (for one patient) at steady state. Infant drug exposure was estimated as the product of an assumed milk production rate and average drug concentration in milk, normalized to body weight, and expressed as a percentage of maternal drug dose, normalized to body weight. RESULTS: The median infant dose of olanzapine ingested through milk was 1.02% of the maternal dose; the median milk-to-plasma area-under-the-curve ratio was 0.38 for the six patients with data collected over the dose interval. Corresponding values in the patient with single-point data were 1.13% and 0.75. Olanzapine was not detected in the plasma of the six infants with an evaluable plasma sample. All of the infants were healthy and experienced no side effects. CONCLUSIONS: Breast-fed infants were exposed to a calculated olanzapine dose of approximately 1%-well below the 10% notional level of concern. In infant plasma, olanzapine was below the detection limit; there were no adverse effects on the infants. These data support the use of olanzapine during breast-feeding. However, the authors recommend that breast-fed infants be monitored closely and the decision to breast-feed be made after individual risk-benefit analysis. |
| | |
Authors:
|
Sharon J Gardiner; Judith H Kristensen; Evan J Begg; L Peter Hackett; Debbie A Wilson; Kenneth F Ilett; Rolland Kohan; Jonathan Rampono |
Related Documents
:
|
12410194 - A breast-feeding assessment score to evaluate the risk for cessation of breast-feeding ... 15138524 - Breast feeding in a saudi arabian community. profile of parents and influencing factors. 4038424 - The human weaning process. 12319244 - Awareness about infant feeding practices among nursing personnel. 17347364 - More than maternal sensitivity shapes attachment: infant coping and temperament. 22734604 - Use of baby carriers to increase breastfeeding duration among term-infants: the effects... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The American journal of psychiatry Volume: 160 ISSN: 0002-953X ISO Abbreviation: Am J Psychiatry Publication Date: 2003 Aug |
Date Detail:
|
Created Date: 2003-08-05 Completed Date: 2003-09-05 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 0370512 Medline TA: Am J Psychiatry Country: United States |
Other Details:
|
Languages: eng Pagination: 1428-31 Citation Subset: AIM; IM |
Affiliation:
|
Department of Clinical Pharmacology, Christchurh Hospital, New Zealand. sharon.gardiner@cdhb.govt.nz |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Antipsychotic Agents / analysis, blood, pharmacokinetics* Area Under Curve Benzodiazepines Breast Feeding* Chromatography, High Pressure Liquid Dose-Response Relationship, Drug Female Humans Infant Male Milk, Human / chemistry, metabolism* Pirenzepine / analogs & derivatives*, analysis, blood, pharmacokinetics* |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 12794-10-4/Benzodiazepines; 132539-06-1/olanzapine; 28797-61-7/Pirenzepine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and cau...
Next Document: Are benzodiazepines still the medication of choice for patients with panic disorder with or without ...